ANA News
June 14, 2021 - The NFL-NFLPA Pain Management Committee (PMC) has launched a formal Request for Proposal (RFP) process aimed at supplementing the PMC's knowledge about pain management and the potential effects of pain and cannabinoids on athletic performance in elite football players.
The goal of...
June 10, 2021 - Nature Research Awards for Inspiring Women in Science
Application Deadline: Sunday, June 20, 2021 | 23:59 BST
Nature Research Awards for Inspiring Women in Science are now open for applications. Awards are available in two categories:
Science Outreach Category
Scientific...
June 9, 2021 - We spoke with ANA Past President David Holtzman, MD, the Andrew B. and Gretchen P. Jones Professor and Chairman of Neurology, Professor of Developmental Biology, Associate Director of the Alzheimer’s Disease Research Center, and scientific director of the Hope Center for...
June 7, 2021 - Today, the U.S. Food and Drug Administration approved Aduhelm (aducanumab) for the treatment of Alzheimer’s, a debilitating disease affecting 6.2 million Americans. Aduhelm was approved using the accelerated approval pathway, which can be used for a drug for a serious or life-threatening illness...
June 7, 2021 - The American Brain Coalition (ABC) and American Neurological Association (ANA) have joined forces to present the Advocacy 101 Series, a tool to help advocates at all levels successfully navigate the halls of Congress—virtually or in-person—and to establish and maintain...